Cargando…
Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease
BACKGROUND: The etiology of inflammatory bowel disease (IBD) is multifactorial and thought to be influenced by inappropriate activation of the gut mucosal immune system. As the only immunoglobulin G (IgG) subclass unable to activate the classical complement cascade, the role of IgG4 in IBD pathophys...
Autores principales: | Chase, R. Christopher, Tamim, Hani, Sheikh, Walaa G. El, Clift, Kristin, Bruining, David, Ha, Christina, Farraye, Francis A., Hashash, Jana G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304528/ https://www.ncbi.nlm.nih.gov/pubmed/37396005 http://dx.doi.org/10.20524/aog.2023.0807 |
Ejemplares similares
-
On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease
por: Hashash, Jana G, et al.
Publicado: (2021) -
Health Maintenance for Adult Patients with Inflammatory Bowel Disease
por: Hashash, Jana G., et al.
Publicado: (2021) -
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
por: Hashash, Jana G., et al.
Publicado: (2023) -
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
por: Desai, Aakash, et al.
Publicado: (2023) -
Significance of granulomas in the outcomes of Crohn’s disease patients
por: Saade, Marie Christelle, et al.
Publicado: (2022)